Literature DB >> 24441100

Loss of AMPKα1 expression is associated with poor survival in melanoma patients.

Madhuri Bhandaru1, Magdalena Martinka2, Gang Li1, Anand Rotte3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24441100     DOI： 10.1038/jid.2014.26

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  15 in total

1.  The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival.

Authors:  W N William; J-S Kim; D D Liu; L Solis; C Behrens; J J Lee; S M Lippman; E S Kim; W K Hong; I I Wistuba; H-Y Lee
Journal:  Ann Oncol       Date:  2011-03-23       Impact factor: 32.976

Review 2.  Therapy for metastatic melanoma: the past, present, and future.

Authors:  Laura Finn; Svetomir N Markovic; Richard W Joseph
Journal:  BMC Med       Date:  2012-03-02       Impact factor: 8.775

3.  [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

Authors:  W Remmele; H E Stegner
Journal:  Pathologe       Date:  1987-05       Impact factor: 1.011

4.  Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner.

Authors:  Michaël Cerezo; Mélanie Tichet; Patricia Abbe; Mickaël Ohanna; Abdelali Lehraiki; Florian Rouaud; Maryline Allegra; Damien Giacchero; Philippe Bahadoran; Corine Bertolotto; Sophie Tartare-Deckert; Robert Ballotti; Stéphane Rocchi
Journal:  Mol Cancer Ther       Date:  2013-06-05       Impact factor: 6.261

5.  Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor.

Authors:  Jennifer G Pryor; Brigette A Brown-Kipphut; Anwar Iqbal; Glynis A Scott
Journal:  Am J Dermatopathol       Date:  2011-12       Impact factor: 1.533

6.  Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation.

Authors:  Che-Hung Shen; Ping Yuan; Rolando Perez-Lorenzo; Yaqing Zhang; Sze Xian Lee; Yang Ou; John M Asara; Lewis C Cantley; Bin Zheng
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

7.  Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation.

Authors:  Bin Zheng; Joseph H Jeong; John M Asara; Yuan-Ying Yuan; Scott R Granter; Lynda Chin; Lewis C Cantley
Journal:  Mol Cell       Date:  2009-01-30       Impact factor: 17.970

8.  Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma.

Authors:  Ping Yuan; Koichi Ito; Rolando Perez-Lorenzo; Christina Del Guzzo; Jung Hyun Lee; Che-Hung Shen; Marcus W Bosenberg; Martin McMahon; Lewis C Cantley; Bin Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

9.  A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF.

Authors:  V Borgdorff; U Rix; G E Winter; M Gridling; A C Müller; F P Breitwieser; C Wagner; J Colinge; K L Bennett; G Superti-Furga; S N Wagner
Journal:  Oncogene       Date:  2013-06-03       Impact factor: 9.867

10.  Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.

Authors:  Longyi Zheng; Wen Yang; Fuquan Wu; Chao Wang; Lexing Yu; Liang Tang; Bijun Qiu; Yuqiong Li; Linna Guo; Mengchao Wu; Gensheng Feng; Dajin Zou; Hongyang Wang
Journal:  Clin Cancer Res       Date:  2013-08-13       Impact factor: 12.531
View more
  7 in total

1.  Metabolic vulnerability in melanoma: a ME2 (me too) story.

Authors:  Bin Zheng; David E Fisher
Journal:  J Invest Dermatol       Date:  2015-03       Impact factor: 8.551

Review 2.  Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies.

Authors:  Giorgia Zadra; Julie L Batista; Massimo Loda
Journal:  Mol Cancer Res       Date:  2015-05-08       Impact factor: 5.852

3.  Genetic variant of PRKAA1 and gastric cancer risk in an eastern Chinese population.

Authors:  Li-Xin Qiu; Jing He; Lei Cheng; Fei Zhou; Meng-Yun Wang; Meng-Hong Sun; Xiao-Yan Zhou; Jin Li; Wei-Jian Guo; Ya-Nong Wang; Ya-Jun Yang; Jiu-Cun Wang; Li Jin; Xiao-Dong Zhu; Qing-Yi Wei
Journal:  Oncotarget       Date:  2015-12-15

4.  Prognostic significance of AMPK in human malignancies: A meta-analysis.

Authors:  Ji Cheng; Xiaoming Shuai; Jinbo Gao; Ming Cai; Guobin Wang; Kaixiong Tao
Journal:  Oncotarget       Date:  2016-11-15

Review 5.  Association between PRKAA1 rs13361707 T>C polymorphism and gastric cancer risk: Evidence based on a meta-analysis.

Authors:  You Jiang; Wenbo Li; Jun Lu; Xin Zhao; Liang Li
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

6.  AMPKα1 confers survival advantage of colorectal cancer cells under metabolic stress by promoting redox balance through the regulation of glutathione reductase phosphorylation.

Authors:  Ying-Nan Wang; Yun-Xin Lu; Jie Liu; Ying Jin; Hui-Chang Bi; Qi Zhao; Ze-Xian Liu; Ying-Qin Li; Jia-Jia Hu; Hui Sheng; Yi-Ming Jiang; Chao Zhang; Feng Tian; Yang Chen; Zhi-Zhong Pan; Gong Chen; Zhao-Lei Zeng; Kai-Yan Liu; Marcia Ogasawara; Jin-Ping Yun; Huai-Qiang Ju; Jian-Xiong Feng; Dan Xie; Song Gao; Wei-Hua Jia; Scott Kopetz; Rui-Hua Xu; Feng Wang
Journal:  Oncogene       Date:  2019-09-17       Impact factor: 9.867

7.  PRKAA1 Promotes Proliferation and Inhibits Apoptosis of Gastric Cancer Cells Through Activating JNK1 and Akt Pathways.

Authors:  Yangmei Zhang; Xichang Zhou; Long Cheng; Xiang Wang; Qinglin Zhang; Youwei Zhang; Sanyuan Sun
Journal:  Oncol Res       Date:  2019-09-26       Impact factor: 5.574
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.